Cytokinetics Announces Secondary Analysis of GALACTIC-HF Presented in Late Breaking Clinical Trial Session at the American College of Cardiology 70th Annual Scientific Session and Published in the Journal of American College of Cardiology

NASDAQ Market News

NEXT STORY
Predictmedix Announces Technology Deployment at Hockeyfest in Partnership With Jones Entertainment Group
PREV STORY
Black Diamond Therapeutics to Host Webcast Presentation of Data From Phase 1 Dose-Escalation Portion of MasterKey-01 Clinical Trial
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Douglas Hamilton, M.D. Offers Patients a Permanent Solution to Acne Scars with Bellafill

Los Angeles, Dec. 10, 2015 (GLOBE NEWSWIRE) -- Assistant Clinical Professor of Dermatology at ...

author_avatar
NASDAQ Market News

Upon Successful Completion of Cohort 3, Cellectar Biosciences Initiates Fourth Cohort of Its Phase I Clinical Trial of CLR 131 in Multiple Myeloma

MADISON, Wis., Feb. 22, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused ...

author_avatar
NASDAQ Market News

Aptevo Therapeutics Announces New IXINITY Supply Available May 2017

SEATTLE, March 15, 2017 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq:APVO), a biotechnology company ...

author_avatar
NASDAQ Market News